ascopubs.org

Use of circulating tumor DNA (ctDNA) in the detection of residual disease and recurrence for patients with testicular cancer.

Circulating tumor DNA (ctDNA) as a real-time biomarker in marker-negative germ cell tumors (GCT): A proof-of-concept study. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary Cancers ...
ascopubs.org

Use of ultra-sensitive whole genome circulating tumor DNA detection to predict early recurrence in high-risk localized RCC after nephrectomy: Preliminary real-world findings.

Use of spatial transcriptomics to analyze the molecular landscape of tuberous sclerosis complex–associated angiomyolipoma: Implications for diagnosis and therapeutic targeting.
IEEE

Efficient Liver and Tumor Segmentation Using a Compact Residual Network and Contrast-Enhanced Pre-Processing Pipeline

Abstract: Accurate liver and tumor segmentation in CT images is vital for diagnosis and treatment planning. This study presents SegResNet_2335, a lightweight 3D residual network optimized for ...
Joplin Globe

Duly Surgeon First in Illinois to Use Tumor-Illuminating Technology for Ovarian Cancer Surgery

DOWNERS GROVE, IL / ACCESS Newswire / February 25, 2026 / Duly Health and Care this month announced that Dr. Sameer Sharma, a gynecologic oncologist at Duly Health and Care's Chicagoland med­ical ...
WebMD

FDA Approves Rybrevant Faspro: A Time-Saving Under-the-Skin Injection for Use in Combination With Lazcluze for EGFR-Mutated Lung Cancer

What Is It, and Why Does It Matter? Rybrevant Faspro is a new under-the-skin (subcutaneous, or SC) injection form of the anticancer medicine Rybrevant (amivantamab). The FDA has now approved it in ...
Investigate Midwest

Pesticide use and cancer risk rise together across America’s heartland

Lisa Lawler wasn’t surprised when diagnosed with breast cancer in 2025. Her mother had breast cancer and died in 2016. It seemed like cancer had become a common diagnosis for many of her neighbors and ...